Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5277_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Preface
- •About the Editors
- •Contributors
- •1.1 Metals as a Bioactive Material
- •1.2 Bioactive Glasses
- •1.4 Closing Remarks
- •References
- •2.1.1 Bioactive Glasses for Bone Tissue Engineering Applications
- •2.1.1.1 Silicate‑Based Bioactive Glasses
- •2.1.1.2 Phosphate‑Based Bioactive Glasses
- •2.1.1.3 Borate‑Based Bioactive Glasses
- •2.1.1.4 Bioactive Glass‑Ceramics
- •2.1.1.5 Composite Bioactive Materials
- •2.1.2 Bioactive Glasses Sustained Drug Release Applications
- •2.1.2.1 Mechanisms of Drug Release
- •2.1.2.3 Applications in Biomedical Therapeutics
- •2.1.2.4 Advantages over Conventional Drug Delivery Systems
- •2.1.2.5 Encapsulation of Drugs
- •2.1.3 Bioactive Glasses for Therapeutic Applications
- •2.1.3.1 Silicate‑Based Bioactive Glasses
- •2.1.3.2 Phosphate‑Based Bioactive Glasses
- •2.1.3.3 Borate‑Based Bioactive Glasses
- •2.1.3.4 Composite‑Based Bioactive Glasses
- •2.1.3.5 Silver‑Based Bioactive Glasses
- •2.1.3.6 Copper‑Based Bioactive Glasses
- •2.1.3.7 Zinc‑Based Bioactive Glasses
- •2.2 Biocompatibility of the Bioactive Glasses
- •2.3 Cytotoxicity of Bioactive Glasses
- •2.1 Bioactive Glasses
- •2.3.1 Standardized in Vitro Assays
- •2.3.2 Effects on Cell Viability
- •2.3.3 Influence of Glass Composition
- •2.3.4 Surface Modification and Cytocompatibility
- •2.3.5 Influence of Degradation Products
- •2.3.6 Long‑Term Cytotoxicity Assessment
- •2.4 Luminescence Characteristics
- •2.4.1 Origins of Luminescence
- •2.4.1.1 Effects of Glass Composition
- •2.4.2 Structural Features and Luminescence
- •2.4.3 Biomedical Applications
- •2.4.4 Characterization Techniques
- •2.5 Functional Characteristics of the Bioactive Glasses
- •2.5.1 Bioactivity and Biomineralization
- •2.5.2 Osteoconductivity and Bone Regeneration
- •2.5.3 Antibacterial Activity
- •2.5.4 Controlled Drug Delivery
- •2.5.5 Angiogenic Potential
- •2.6 Outlook
- •References
- •3.1 Nanomaterials for Biological Applications
- •3.2 Nanomaterials Doped to Bioactive Glasses
- •3.2.1 Alkali Metal‑Based Bioactive Glasses
- •3.3 Alkaline Earth Metals
- •3.4 Transition Metals
- •3.6 Outlook on Stability of NPs
- •References
- •4.1 Introduction
- •4.2.1 Composition and Structure
- •4.2.2 Role of Specific Oxides
- •4.3 Processing Methods
- •4.3.1 Conventional Melting‑Quenching
- •4.3.1.1 Impact on Microstructure and Properties
- •4.3.1.2 Biomedical Relevance
- •4.3.2 Sol‑Gel Process
- •4.3.2.1 Impact on Microstructure and Properties
- •4.3.2.2 Biomedical Relevance
- •4.3.3 Sintering Methods
- •4.3.3.1 Impact on Microstructure and Properties
- •4.3.3.2 Biomedical Relevance
- •4.4 Tailoring Properties for Biological Applications
- •4.4.1 Tissue Engineering
- •4.4.1.1 Scaffold Design
- •4.4.1.2 Bioactivity and Degradation
- •4.4.2 Drug Delivery
- •4.4.2.1 Encapsulation Methods
- •4.4.2.2 Controlled Release
- •4.4.2.3 Therapeutic Applications
- •4.4.3 Biosensing
- •4.4.3.1 Sensor Design
- •4.4.3.2 Detection Mechanisms
- •4.4.3.3 Applications in Diagnostics
- •4.5 Characterization Techniques
- •4.5.1 X‑Ray Diffraction
- •4.5.1.2 Crystallinity
- •4.6.2 Versatility in Processing Techniques
- •4.6.3 Tailoring for Specific Applications
- •4.6.4 Advanced Characterization Techniques
- •4.6.5 Future Directions
- •References
- •5.1 Introduction
- •5.2 In Vitro Behaviours of Bioactive Glasses
- •5.2.1 Simulated Body Fluid Immersion Tests
- •5.2.2 Surface Reactions and Ion Release Kinetics
- •5.2.2.1 Surface Reactions and Ion Release
- •5.2.3 Assessment of Bioactivity
- •5.3 In Vivo Behaviours of Bioactive Glasses
- •5.3.1 Animal Models
- •4.5.2 Scanning Electron Microscopy
- •4.5.2.1 Surface Morphology
- •4.5.2.2 Microstructure
- •4.5.3 Transmission Electron Microscopy
- •4.5.3.1 High‑Resolution Imaging
- •4.5.3.2 Diffraction Studies
- •4.5.4 Atomic Force Microscopy
- •4.5.4.1 Surface Topography
- •4.5.4.2 Mechanical Properties
- •4.5.5 Integration of Characterization Techniques
- •4.5.5.1 Correlation of Data
- •4.5.5.2 Advanced Analytical Technique
- •4.6 Conclusion
- •4.6.1 Integration of Bioactive Components
- •5.3.1.1 Biocompatibility
- •5.3.1.2 Tissue Integration
- •5.3.1.3 Osteoconductivity
- •5.3.2 Clinical Trials
- •5.3.2.1 Safety and Biocompatibility
- •5.3.2.1.1 Multifaceted Safety Net: Monitoring for Adverse Events
- •5.3.2.1.2 A Data‑Driven Approach to Safety
- •5.3.2.2.1 Bone Regeneration
- •5.3.2.2.2 Dental Restoration
- •5.3.2.2.3 Drug Delivery
- •5.3.2.3 Long‑Term Performance
- •5.3.3 Hydroxyapatite Layer Formation
- •5.3.3.1 Hydroxyapatite Formation kinetics
- •5.3.3.2 Quality of the Hydroxyapatite Layer
- •5.3.3.2.1 Translating In Vitro to In Vivo Success
- •5.4.1 Biocompatibility and Tissue Integration
- •5.4.1.1 In Vitro Biocompatibility
- •5.4.1.2 In Vivo Biocompatibility
- •5.4.1.3 Correlating In Vitro and In Vivo Data
- •5.4.1.3.1 Comparative Analysis
- •5.4.1.3.2 Identifying Discrepancies
- •5.4.2 Hydroxyapatite Layer Formation
- •5.4.2.1 In Vitro Hydroxyapatite Formation
- •5.4.2.1.1 Simulated Body Fluid Immersion Tests
- •5.4.2.1.2 Key Indicators of Osteoconductivity
- •5.4.2.2 In Vivo Hydroxyapatite Formation
- •5.4.2.2.1 Assessment Techniques
- •5.4.2.2.2 Indicators of Successful HA Formation
- •5.4.3 Ion Release Kinetics
- •5.4.3.1 In Vitro Ion Release
- •5.4.3.1.1 Experimental Procedure
- •5.4.3.1.2 Analytical Techniques
- •5.4.3.1.3 Kinetics of Ion Release
- •5.4.3.2 In Vivo Ion Release
- •5.4.3.2.1 Monitoring Ion Release In Vivo
- •5.4.3.2.2 Biological Impact of Ion Release
- •5.4.3.2.3 Analysis of Biological Fluids and Tissues
- •5.4.3.2.4 Assessing Implant Performance
- •5.4.3.3 Correlating In Vitro and In Vivo Ion Release Data
- •5.4.3.3.1 Comparative Analysis of Ion Release Data
- •5.4.3.3.2 Interpretation of Correlation Data
- •5.4.3.3.3 Applications of Correlated Data
- •5.4.3.3.4 Methodological Considerations
- •5.5.1 Bone Regeneration
- •5.5.2 Applications in Orthopaedics and Dentistry
- •5.5.2.1 Orthopaedic Implants
- •5.5.2.1.1 Applications in Orthopaedic Implants
- •5.5.2.2 Bone Grafts
- •5.5.2.2.1 Scaffolding for Bone Growth
- •5.5.2.2.2 Gradual Degradation and Replacement
- •5.5.2.2.3 Optimizing Bone Regeneration
- •5.5.2.2.4 Applications in Bone Grafting
- •5.5.2.3 Spinal Fusion
- •5.5.2.3.1 Advantages over Traditional Methods
- •5.5.3 Dental Restoration
- •5.6 Benefits of Bioactive Glasses in Dental Restoration
- •5.6.1 Beyond Basic Restorations
- •5.6.2 Optimizing Bioactive Glasses for Dentistry
- •5.6.2.1 Fillings and Crowns
- •5.6.2.1.2 Beyond Basic Fillings
- •5.6.2.1.3 Optimizing Bioactive Glasses for Dentistry
- •5.6.2.2 Root Canal Therapy
- •5.6.2.2.2 Beyond Basic Sealing
- •5.6.2.2.3 Optimizing Bioactive Glasses for Root Canal Therapy
- •5.6.2.3 Bone Augmentation
- •5.6.2.3.2 Optimizing Bioactive Glasses for Bone Augmentation
- •5.6.3 Drug Delivery Systems
- •5.6.3.1 Controlled Release
- •5.6.3.1.1 Mechanism of Controlled Release
- •5.6.3.1.2 Advantages of Controlled Drug Release
- •5.6.3.1.3 Applications
- •5.6.3.2 Localized Delivery
- •5.6.3.2.1 Mechanism of Localized Drug Delivery
- •5.6.3.2.2 Advantages of Localized Drug Delivery
- •5.6.3.3 Multi‑Functional Carriers
- •5.6.3.3.1 Mechanism of Multi‑Functional Drug Delivery Systems
- •5.6.3.3.2 Advantages of Multi‑Functional Carriers
- •5.6.3.3.3 Applications of Multi‑Functional Bioactive Glass Carriers
- •5.6.3.3.4 Summary
- •5.7 Conclusion
- •References
- •6.1 Introduction
- •6.1.1 Overview of Bioactive Glasses
- •6.1.1.1 Biomineralization Process
- •6.1.1.3 Interfacial Bonding and Tissue Integration
- •6.1.1.4 Applications of BGs
- •6.1.2 MechanosensinG in Biomedical Applications
- •6.2 Cell Proliferation of BGs
- •6.2.1 Cellular Response to BGs
- •6.2.2 Mechanisms of Proliferation
- •6.3 Mechanotransduction of BGs
- •6.3.1 Understanding Mechanotransduction
- •6.3.2 Role of BGs in Mechanotransduction
- •6.3.2.1 Stiffness and Elasticity
- •6.3.2.2 Surface Topography
- •6.3.2.3 Ionic Dissolution Products
- •6.3.2.4 Mechanotransduction Pathways
- •6.3.2.4.1 Integrative Role of Bioactive Glasses
- •6.4 Immune Response: Triggering T and B Antigens
- •6.4.1 BGs and the Immune System
- •6.4.1.1 Initial Immune Response
- •6.4.1.2 Role of Adaptive Immune Cells
- •6.4.1.3 Modulation of Immune Responses
- •6.4.2 Mechanisms of Immune Activation
- •6.4.2.1 Release of Therapeutic Ions
- •6.4.2.1.1 Surface Interactions
- •6.4.2.1.2 Activation of Immune Cells
- •6.4.2.1.3 Activation of Signalling Pathways
- •6.5 Optimization of Bioactive Glass Design
- •6.5.1 Ionic Dissolution Products
- •6.5.1.2 Phosphorus Ions (P)
- •6.5.2 Surface Interactions
- •6.5.2.1 Macrophage Activation and Cytokine Release
- •6.5.2.3 Modulation of Immune Responses for Regenerative Environment
- •6.5.3 Activation of T and B Cells
- •6.5.3.1 T Cell Activation and Proliferation
- •6.5.3.2 B Cell Activation and Antibody Production
- •6.5.4 Influence on Long‑Term Biocompatibility
- •6.6 Cytokine Production and Immune Modulation
- •6.6.1 Pro‑Inflammatory Cytokines
- •6.6.2 Anti‑Inflammatory Cytokines
- •6.6.3 Modulation of Cytokine Profile
- •6.7 Mechanostimulus and BGs
- •6.7.1 Concept of Mechanostimulus
- •6.7.1.2 Cellular Response to Mechanostimuli
- •6.7.1.3 Implications for Biomaterial Design and Tissue Engineering
- •6.7.2 Role of BGs in Providing Mechanostimulus
- •6.7.2.1 Mechanisms of Cellular Response to Stiffness
- •6.7.2.2 Impact of Stiffness on Cellular Functions
- •6.7.2.3 Engineering BGs with Tunable Stiffness
- •6.7.2.4 Mechanisms of Cellular Response to Surface Topography
- •6.7.2.5 Impact of Surface Topography on Tissue Engineering
- •6.7.2.6 Importance of Dynamic Mechanical Loading
- •6.7.3 Role of BGs in Dynamic Loading
- •6.7.3.1 Mimicking the Natural Bone Environment
- •6.8 Mechanotransduction Pathways
- •6.8.1 Integrin‑Mediated Signalling
- •6.8.2 Mapk Signalling Pathway
- •6.8.3 Rho/Rock Signalling Pathway
- •6.9 Synergy with Biochemical Signals
- •6.9.1 Mechanotransduction and Biochemical Signalling
- •6.9.2 Promotion of Cellular Activities
- •6.10.1 Bone Tissue Engineering
- •6.10.1.1 Scaffold Design
- •6.10.1.2 Tailored Mechanical Properties
- •6.10.1.3 Controlled Porosity
- •6.10.1.4 Surface Topography
- •6.10.1.5 Release of Therapeutic Ions
- •6.11 Design and Loading Characteristics
- •6.11.1 Dynamic Loading
- •References
- •7.1 Introduction
- •7.2.1 Bioactivity
- •7.2.2 Biocompatibility
- •7.2.3 Osteogenic Potential
- •7.2.4 Controlled Release of Bioactive Ions
- •7.2.5 Versatility in Formulation and Processing
- •7.2.6 Applications in Tissue Engineering
- •7.2.7 Drug Delivery Systems
- •7.2.8 Antibacterial Properties
- •7.3.1 Material Formulation and Optimization
- •7.3.2 Printability and Scaffold Design
- •7.3.3 Surface Modification and Functionalization
- •7.3.4 Incorporation of Bioactive Glass Nanoparticles
- •7.3.5 Post‑Processing and Surface Finishing
- •7.3.6 Multi‑Material Printing and Hybrid Constructs
- •7.3.7 In Vitro and In Vivo Evaluation
- •7.4 Challenges and Future Directions
- •7.5 Conclusion
- •References
- •8.1 Introduction
- •8.2 Bioactive Glasses: Properties and Considerations
- •8.7 Challenges and Outlook
- •8.7.1 Challenges
- •8.7.1.1 Processing Challenges
- •8.7.1.2 Degradation Control
- •8.7.1.3 Bioactivity and Mechanical Property Balance
- •8.7.1.4 Regulatory Challenges
- •8.7.1.5 Scale‑Up and Cost‑Effectiveness
- •8.7.2 Outlook
- •8.7.2.1 Novel Polymer and Bioactive Glass Combinations
- •8.7.2.2 Multifunctional Nanocomposites
- •8.7.2.3 Advanced Manufacturing Techniques
- •8.7.2.4 In Vivo Performance and Biocompatibility Studies
- •8.7.2.5 Clinical Translation and Commercialization
- •8.8 Conclusion
- •References
- •9.1 Introduction
- •9.2 Focus Materials: Natural and Synthetic
- •9.2.1 Natural Materials
- •9.2.1.1 Collagen
- •9.2.1.2 Chitosan
- •9.2.1.3 Alginate
- •9.2.2 Synthetic Materials
- •9.2.2.1 Poly(Lactic‑co‑Glycolic Acid)
- •9.2.2.2 Polycaprolactone
- •9.2.3 Composite Structures
- •9.2.3.1 Enhanced Mechanical Properties
- •9.2.3.2 Controlled Degradation
- •9.2.3.3 Improved Bioactivity
- •9.3 Surface Functionalization
- •9.3.1 Functionalization Techniques
- •9.3.1.1 Silanization
- •9.3.1.2 Peptide Grafting
- •9.3.1.3 Plasma Treatment
- •9.3.2 Applications of Surface Functionalization
- •9.3.2.1 Bone Regeneration
- •9.3.2.2 Wound Healing
- •9.3.2.3 Drug Delivery
- •9.3.3 Advanced Functionalization Techniques
- •9.3.3.1 Layer‑by‑Layer Assembly
- •9.3.3.2 Bioorthogonal Chemistry
- •9.4 Super Wettable Surfaces
- •9.4.1 Types of Super Wettable Surfaces
- •9.4.1.1 Superhydrophilic Surfaces
- •9.4.1.2 Superhydrophobic Surfaces
- •9.4.2 Fabrication Techniques
- •9.4.2.1 Chemical Etching
- •9.4.2.2 Sol‑Gel Coating
- •9.4.2.3 Plasma Treatment
- •9.4.2.4 Layer‑by‑Layer Assembly
- •9.4.3 Applications of Super Wettable Surfaces
- •9.4.3.1 Tissue Engineering
- •9.4.3.2 Antimicrobial Coatings
- •9.4.3.3 Drug Delivery Systems
- •9.4.4 Future Directions
- •9.4.4.1 Multifunctional Surfaces
- •9.4.4.2 Stimuli‑Responsive Surfaces
- •9.5 Supramolecular Chemistry
- •9.5.1 Principles of Supramolecular Chemistry
- •9.5.2 Applications in Bioactive Glasses
- •9.5.2.1 Self‑Healing Bioactive Glasses
- •9.5.2.2 Controlled Degradation
- •9.5.2.3 Enhanced Bioactivity
- •9.5.3 Fabrication Techniques
- •9.5.3.1 Sol‑Gel Process
- •9.5.3.2 Layer‑by‑Layer Assembly
- •9.5.3.3 3D Printing
- •9.6 Conclusion
- •9.6.1 Advances in Material Composition
- •9.6.2 Surface Functionalization
- •9.6.3 Super Wettable Surfaces
- •9.6.4 Supramolecular Chemistry
- •9.6.5 Future Directions
- •9.6.6 Clinical Implications
- •References
- •10.1 Introduction
- •10.2 Discovery of Bioactive Glasses
- •10.2.1 Historical Background
- •10.2.2 Mechanism of Bioactivity
- •10.2.3 Impact on Biomaterials Science
- •10.3 Clinical Applications
- •10.3.1 Early Clinical Use
- •10.3.2 Expansion and Widespread Adoption
- •10.3.3 Specific Case Studies and Clinical Outcomes
- •10.3.4 Regulatory Approvals and Market Adoption
- •10.3.4.1 Incorporation of Therapeutic Agents
- •10.3.4.2 Applications in Clinical Settings
- •10.4 Tissue Regeneration
- •10.4.1 Mechanisms of Tissue Regeneration
- •10.4.1.1 Mechanisms of Osteogenic Stimulation
- •10.4.1.1.1 Ionic Dissolution and Release
- •10.4.1.1.2 Activation of Signalling Pathways
- •10.4.1.1.3 Hydroxyapatite Formation
- •10.4.2 Applications in Tissue Regeneration
- •10.4.3 Clinical Applications and Success Stories
- •10.5 Innovation in Bioactive Glasses
- •10.5.1 Development of Advanced Compositions
- •10.5.1.1 Incorporation of Additional Elements
- •10.5.2 Future Research Directions
- •10.5.3 Potential Non‑Skeletal Applications of Bioactive Glasses
- •10.5.3.1 Cardiovascular Implants
- •10.5.3.2 Wound Healing Dressings
- •10.5.3.3 Neural Tissue Regeneration
- •10.5.3.4 Key Biomimetic Design Approaches
- •10.5.3.4.1 Hierarchical Structure
- •10.5.3.4.2 Functionalization with Biologics
- •10.5.3.4.3 Dynamic Response to Environmental Stimuli
- •10.5.4.1 Bone Regeneration
- •10.5.4.2 Dental Applications
- •10.5.4.3 Soft Tissue Engineering
- •10.5.4.4 Collaborative Efforts for Standardization
- •10.5.4.5 Implementation of Quality Management Systems
- •10.6 Industrial Compliance
- •10.6.1.1.1 Medical Devices
- •10.6.1.2 Cytotoxicity Testing
- •10.6.1.2.1 Cell Viability Assays
- •10.6.1.2.2 Genotoxicity Testing
- •10.6.1.2.3 Immunogenicity Testing
- •10.6.1.2.4 Hemocompatibility Testing
- •10.6.2 Quality Control and Standardization
- •10.6.3 International Harmonization and Collaboration
- •10.7 Life Cycle Analysis
- •10.7.1 Methodology of Life Cycle Analysis
- •10.7.2 Environmental Impact and Sustainability
- •10.7.2.1 Challenges and Opportunities
- •10.7.3 Sustainable Practices and Continuous Improvement
- •10.8 Challenges and Solutions
- •10.8.1 Overcoming Regulatory Hurdles
- •10.8.2 Enhancing Industrial Processes
- •10.8.3 Addressing Environmental Concerns
- •10.9 Future Outlook and Innovation
- •10.9.1 Advancements in Material Science
- •10.9.2 Sustainable Manufacturing Practices
- •10.9.3 Digitalization and Industry 4.0 Integration
- •10.9.4 Collaboration and Interdisciplinary Research
- •10.10 Conclusion and Recommendations
- •10.10.1 Key Takeaways
- •10.10.2 Recommendations for Future Action
- •References
- •Index

xii Contributors
Kondaiah Gudimetla
Department of Mechanical Engineering
Pace Institute of Technology & Sciences
Ongole, India
Raghavendra Gujjala
Department of Mechanical Engineering
NIT Warangal
Telangana, India
Ramu Inala
Department of Mechanical Engineering
Vishnu Institute of Technology
Bhimavaram
Andhra Pradesh, India
S. Indran
Research Scientist, Department
of Materials and Production
Engineering
King Mongkut’s University of
Technology
North Bangkok, Thailand
Satish Jain
Department of Mechanical Engineering
NITWarangal
Telangana, India
Rakesh Kanakam
Department of Mechanical
Engineering
NIT Warangal
Telangana, India
Yugesh A. Kharche
Department of Mechanical
Engineering
Padmashri Dr.V.B. Kolte College of
Engineering
Malkapur, Maharashtra, India
Vishnu Vijay Kumar
International Institute of Aerospace
Engineering and Management
JAIN (Deemed-to-be-University)
Bangalore, Karnataka, India
Akanksha Mohanty
Department of Biomedical Engineering
NIT Rourkela
Odisha, India
Muhammad Akhsin Muikhun
Mechanical and Industrial Engineering
Department
Gadjah Mada University
Yogyakarta, Indonesia
M. S. Narayanan
Department of Biotechnology
Indian Institute of Technology Madras
Tamil Nadu, India
P. Navaneethakrishnan
Department of Energy Science and
Engineering
Indian Institute of Technology Bombay
Mumbai, India
Shakuntala Ojha
Department of Mechanical Engineering
Pace Institute of Technology & Sciences
Ongole, India
Mutlu Özcan
Center for Dental Medicine
Clinic of Masticatory Disorders and
Dental Biomaterials
University of Zurich
Zurich, Switzerland
R. G. Asuwin Prabu
School of Bioscience and Technology
Vellore Institute of Technology
Vellore, India
Department of Applied Mechanics and
Biomedical Engineering
Indian Institute of Technology Madras
Tamil Nadu, India
P. Syam Prasad
Department of Physics
NIT Warangal
Telangana, India

xiiiContributors
P. Phani Prasanthi
Department of Mechanical Engineering
PVP Sidhartha Institute of Technology
Andhra Pradesh, India
K. G. Prashanth
Department of Mechanical and
Industrial Engineering
Tallinn,Estonia
Shanmukha Raju
Department of Pharmacy
University College of Technology
Osmania University
Hyderabad, Telangana, India
Parthiban Ramaswamy
Erich Schmid Institute of Material
Science of the Austrian Academy of
Sciences
Leoben, Austria
H. Jeevan Rao
Department of Aerospace, AIAE
Amity University
Noida, India
P. Venkateswara Rao
Department of Physics
TheUniversity of West Indies
Mona Campus, Jamaica
Manuela Reben
Department of Glass Technology and
Amorphous Coatings
Faculty of Materials Science and
Ceramics
AGH University of Science and
Tech n ology
Kra kow, Pola n d
S. Shiva
Department of Mechanical
Engineering
Centre for Nanotechnology &
Sustainability
National University of
Singapore
Singapore
School of Bioscience and
Tech n ology
Vellore Institute of
Tech n ology
Vellore, India
Y. B. Sudhir Sastry
Department of Aerospace
Engineering
IIAEM, Jain University
Bangalore, Karnataka,
India
Santosh R. Shekokar
Department of Mechanical
Engineering
Padmashri Dr.V.B. Kolte College of
Engineering
Malkapur, Maharashtra, India
Nadeem Siddiqui
Department of Biotechnology
Koneru Lakshmaiah Education
Foundation
Andhra Pradesh, India
Ishika Singh Solanki
Scholar, Department of Aerospace
Engineering
Jain University
Bangalore, Karnataka, India

xiv Contributors
Shrishail B. Sollappur
International Institute of Aerospace
Engineering and Management
Jain deemed-to-be-University, JGI
Global Campus
Bangalore, Karnataka,
India
Marcin Środa
Department of Glass Technology and
Amorphous Coatings
Faculty of Materials Science and
Ceramics
AGH University of Science and
Technology
Krakow, Pola nd
Riessom Weldegiorgis
Institute of Research and
Development
Director for Flight Dynamics and
Control Center Bishoftu
Bishoftu, Ethiopia

1
Introduction to
Bioactive Materials
Metals to Non‑metals
Dheeraj K. Gara, Raghavendra Gujjala,
P. Syam Prasad, Madaboosi. Srinivasan.
Narayanan and Mutlu Özcan
1.1 METALS AS A BIOACTIVE MATERIAL
Basically, metals are used as biocompatible materials rather than bioactive materials
due to their bulk nature that a human body cannot afford. Conventional metals such
as aluminium, titanium, copper, mild steel, nickel and other transition block elements
which are anticorrosive in nature can be used as implants in bulk form as a support
system to enable the growth of the bone or sometimes as a permanent implant. This
literature dates back to the early 18th century of using metals as implants; however,
over more than a century, this practice was followed by the clinicians to treat mostly
various bone-related issues such as cartilage damages, osteoporosis and arthritis.
When titanium is considered, it is a popular material for bone implants due to its
biocompatibility, strength and light weight. It is also corrosion resistant and has a
low modulus of elasticity, which means it is exible enough to move with the bone
without causing pain or discomfort. It is used in joint replacement, fracture xation,
spinal fusion and dental implants. Likewise, aluminium was found to be one of the
potential materials for biomedical applications due to its interesting properties such
as biocompatibility, light weight and strength; i.e., high strength to weight ratio, cor-
rosion resistance and Osseointegration potential make them more versatile. Unlike
the titanium, the Osseo integration potential of the aluminium makes it potential for
biological applications, since the process of Osseo integration involves the bonding
of the bone tissue and promoting the growth through exchange of ions. Such materi-
als are referred to as bioactive materials and lie in the interest of the current scientic
community. However, excess amount of aluminium can result in adverse effects such
as induced cytotoxicity due to degradation of excess aluminium ions and limited
applications such as dental and orthopaedic applications where their properties are
particularly benecial.
Considering one more potential material from the transition group, nickel also has
potential for use in biomedical applications as implants, but they were found to be
very limited due to their allergic reaction observed in many of the individuals who
are treated for the same. Hence, it is ensured that before using nickel as an implant,
1

2 Bioactive Glass Materials for Biological Applications
a previous medical history of the allergy reaction towards metals is to be taken into
consideration, whereas the most versatile material used in biomedical applications is
stainless steel. Stainless steel is a versatile and commonly used material for biomedi-
cal applications due to its excellent corrosion resistance, biocompatibility and good
mechanical properties. It is used in a wide range of medical devices that includes
orthopaedic implants, such as hip and knee replacements, as well as dental implants.
It is also used for some cardiovascular implants, such as stents and valves, and sur-
gical instruments, such as scalpels, forceps and clamps. It is also used for a variety
of other medical devices, such as needles, syringes and catheters, and sterilization
equipment, such as autoclaves and ovens. It is also used for laboratory equipment
and other medical equipment. The properties of the stainless steel include corrosion
resistance, biocompatibility, strength and durability and ease to clean and sterilize.
On the other side, other problems include wear and tear over time and inference for
medical imaging procedures due to their strong magnetic properties.
Cobalt-chromium (Co-Cr) alloys are a class of materials that have gained signi-
cant traction in the eld of biomedical applications due to their remarkable combina-
tion of properties. These alloys exhibit exceptional corrosion resistance, high strength
and toughness, biocompatibility and wear resistance, making them ideal candidates
for various medical implants and devices. Few properties of these alloys include cor-
rosion resistance, high strength and toughness, biocompatibility and excellent wear
resistance. They have foreseen few applications such as orthopaedic implants, den-
tal implants, cardiovascular devices and surgical instruments. Alongside, they also
have amenability towards inducing bioactivity in the form of Osseo integration and
biodegradation.
Another interesting material tantalum is valued for its remarkable properties
that make it an ideal material for various implants and devices. Tantalum is con-
sidered biocompatible, meaning it is well-tolerated by the human body and has a
low risk of triggering adverse reactions or causing tissue damage. This property
makes it suitable for long-term implantation without the risk of rejection or inam-
matory responses. Tantalum also exhibits exceptional resistance to corrosion in
various bodily uids, making it a durable and long-lasting material for implants.
Its inertness prevents the release of harmful ions into the body, further enhancing
its biocompatibility. It also possesses high strength and stiffness, making it suit-
able for load-bearing implants, such as orthopaedic components. Its mechanical
properties can be tailored through alloying and processing techniques to match
the specic requirements of different applications. Tantalum has demonstrated the
ability to bond with bone tissue, a process known as Osseo integration. This prop-
erty promotes the stability and long-term success of bone implants, particularly in
orthopaedic and dental applications. Tantalum is radiopaque, meaning it is visible
under X-rays and other imaging modalities. This property allows for easy tracking
of implants during surgery and follow-up assessments, aiding in patient care and
monitoring implant performance. Based on various applications, these different
materials are used in versatile locations in the human body as implants as shown
in Figure1.1.
Alongside these metals, we shall discuss most common metal ions used as a
dopants in the bioactive glasses that are displayed in Figure1.2. These are used in

3Introduction to Bioactive Materials: Metals to Non-metals
analogues to the bioactive glasses. However, a comprehensive list of the metals and
their applications towards biological applications can be inferred in Table1.1.
1.2 BIOACTIVE GLASSES
The spongy centre of the bone consists of stem cells that progenitors into mesenchy-
mal stem cells aiding in the repair, development and growth of the bone through the
supply of osteogenic cells [42]. When a biomaterial is implanted in the site of the
fracture or defect, it requires a delivery vehicle for the carrying of proteins to the
bone marrow where mesenchymal cells promote bone regeneration. The most abun-
dant protein in the bone is Type I Collagen, and interestingly, this is synthesized by
osteoblasts. However, there is a lot of disambiguation in the scientic text, whether
osteoblasts directly synthesize Type I Collagen or by forming precursors of osteo-
cytes. From our earlier understanding, osteocytes perform traverse control of ions
from minerals into bone via canaliculi, realizing that matured osteoblast differenti-
ated from osteoblasts will synthesize the Type I Collagen protein. One more strong
FIGURE1.1 Various metals used as implants in bone tissues

4 Bioactive Glass Materials for Biological Applications
TABLE1.1
List of metal‑based bioactive materials for versatile biological applications
Groups Elements Bioactivity References
Alkali metals Lithium Angiogenesis and osteogenesis [1–4]
Sodium Improved hydroxyapatite formation
Potassium Delays the tendency of crystallization
Rubidium Cell adhesion, proliferation and ALP activity.
Alkaline earth
metals
Magnesium Antimicrobial activity, enhanced apatite layer
formation
[5–8]
Calcium Major constituent mineral of the bone which
forms apatite.
Strontium Early osseointegration
Barium Better biological radiation resistance/better
opacier
Transition metals Yttrium Improves chemical durability [9–24]
Titanium Lesser or no bioactivity
Zirconia Increases antibacterial activity
Vanadium Cerium ions improve the blood vessel
formations and no antibacterial activity but
lower angiogenesis
Niobium Enhanced cell proliferation and stimulated
osteogenic differentiation
Tantalum Antibacterial and antifungal, non-toxic and
simulated Osseo integration.
Chromium No bioactivity
Molybdenum Promotes the osteogenic gene expressions of
collagen I secretion and bone sialoprotein in
ADSCs.
Manganese Antibacterial activity/improves adhesion and
proliferation of osteoblastic-like cells
(MC3T3E1)
Rhenium Biocompatibility and osteoconductivity
Iron Bone cancer nanotherapeutics
Cobalt Enhances the hydroxyapatite layer formation
Nickel Better density and mechanical properties can
be increased
Copper For antimicrobial properties to the bioglass
Silver Antimicrobial property to the bioglass
Gold Optimal cellular proliferation, decent
angiogenesis, enhanced vimentin positive
cells
Zinc and
Cadmium
Able to stimulate osteoblast differentiation and
mineralization by enhancing the osteogenic
genes expression.
(continued)

5Introduction to Bioactive Materials: Metals to Non-metals
Groups Elements Bioactivity References
Post-transition
metals
Aluminium Accelerates the rate of osteoprogenitor cell
differentiation and formation of osteoid
nodules alongside inhibiting mineralization.
[25–27]
Gallium Absence of antibacterial activity/lower
angiogenesis.
Bismuth Antimicrobial activity, promotes osteogenic
cell proliferation, differentiation and
mineralization.
Metalloids Boron An excellent substrate for cell adhesion,
differentiation and proliferation and capable
of promoting osteogenesis and
neovascularization.
[28–31]
Silica Main constituent of bone, formation of
hydroxyapatite.
Germanium Treatment of cancer, arthritis and senile
osteoporosis due to the therapeutic attributes
such as immune enhancement, oxygen
enrichment and heavy metal detoxication.
Tellurium Antibacterial, antioxidant and radiation
shielding properties.
Reactive
non-metals
Phosphorous Main constituent in human body and enables
ion transfer.
[32, 33]
Selenium Drug-delivery system for bone therapy, tissue
regeneration, accelerates mineralization
process.
Lanthanides Lanthanum Enhanced osteoblast performance by
promoting differentiation and proliferation,
by raising protein expression.
[34–40]
Cerium Absence of antibacterial activity
Samarium Improved osteoblastic cell response and higher
cell proliferation
Europium Can be used for labelling bone marrow stromal
cells, enhanced osteogenic gene expression
Gadolinium Promotes osteogenic differentiation of human
bone marrow-derived mesenchymal stem
cells.
Terbium Radiation shielding characteristic
Erbium Radiation shielding characteristic
TABLE1.1
(Continued)

6 Bioactive Glass Materials for Biological Applications
understanding is that the protein concentration is lower in interstitial uid present in
bone marrow and thus osteocytes participate in mineralization and osteoblasts par-
ticipate in bone strengthening. An understanding of ion behaviour in osteocytes and
osteoblasts can be realized from Figure1.3.
The biomechanics of the bone is controlled and monitored at a micro and some-
times at mesoporous scale through altering mineral and protein nutrient ions. It is
clinically evident that transition metals due to their advantage of electronic congu-
rations are best suitable for the protein ions, whereas alkali earth metals for min-
eral ions [43, 44]. The implants made of these materials in the current scientic
community are referred to as bioactive glasses. Bioglass 45S5 is the rst of its kind
in bioactive glass which received wide attention in terms of clinical compliance.
Classic Bioglass [45] constitutes the composition of 45 wt% SiO
2
, 24.5 wt%CaO,
24.5 wt%Na
2
O and 6 wt%P
2
O
5
.
This bioglass is implanted at the fracture sight, where ion transport is disconnected
and growth factors’ accumulation will be very slow or sometimes may not be possible
if the intensity of crack magnitude is severe. Immediately the sodium and calcium ions
on the glass surface rapidly begin exchange of ions with the hydrogen ions present
in the physiological body uid particularly intracellular. This intracellular uid has
more charged macromolecules and high alkali ion concentrations that are referred to
as cytosol [46]. Cytosol is involved in various cell signalling, pertaining to the current
context; calcium and sodium signalling are few amongst others and enable exchange of
ions with hydrogen carriers to the bioglass comprising of calcium and sodium. This ion
exchange takes place until silane groups condense to the silica gel layer which forms
the bridge between the fracture mode as displayed in Figure1.3.
FIGURE1.2 Biologically active ions used for biological applications [41]

7Introduction to Bioactive Materials: Metals to Non-metals
Now calcium and phosphate (either from body uid or from simulated body uid
(SBF)) ions pleat at the silica gel and assimilate carbonate and hydroxyl ions from
the extracellular uid that forms a layer modifying the silica network with rich car-
bonated hydroxyapatite (HA). This phase, in coalescence, works with the native
tissue for the regeneration through exchange of ions and hence BAGs are referred
to as bio-coalescent materials. Most commonly observed phosphorus apatite min-
eral conguration is hydroxyl apatite, however few other apatite congurations such
as uorapatite and chlorapatite are also cited in the literature for tissue regenera-
tion applications. From the literature, it can be pursued that hydroxyl apatite shows
greater ability to form apatite compared to that of uorapatite but has lower osteo-
calcin synthesis [47]. Nevertheless, chlorapatite received contemplation in literature,
but it hasn’t shown much potential for clinical compliance. One must realize that
sodium used in the current bioglass assimilates with chlorine thus forming a salt,
sodium chloride, which actually tunes the bone resorption rate relative to bone for-
mation rate. Since the percentage of chlorine present is very minute, the chlorapatite
is ignored, but at an ionic scale its impact is decipherable. Hence, a bioglass combi-
nation with the addition of uorine and chlorine is also of equal importance where
biomimicking is desired. There is no such work cited in the literature as in contrast
to the bone tissue engineering applications in this combination and hence an under-
standing in this context can show some signicant potential. We shall now discourse
on the development of materials that exhibit bioactivity, biocompatibility and bio-
mimicking. It is understood by nature that the human body poses a large number of
materials in appropriate compositions with respect to the majority of elements within
the body. The term biocompatibility in context to the bone tissue engineering refers
to cytotoxicity and genotoxicity. Metals that are used as a constituent in process-
ing the bioglass should be biocompatible and bioactive in nature. Table1.2 displays
various classic bioglass congurations with different dopants as metals, and their
characteristic enhancements in terms of mechanical and biological parameters are
emphasized [47–57].
FIGURE1.3 ECM-BG coalescence for tissue regeneration
Соседние файлы в папке Библиотека им академика М.И. Перельмана
